| Efficacy of tocilizumab in patients hospitalized with Covid-19 JH Stone, MJ Frigault, NJ Serling-Boyd, AD Fernandes, L Harvey, ... New England Journal of Medicine 383 (24), 2333-2344, 2020 | 1473 | 2020 |
| Myocarditis in patients treated with immune checkpoint inhibitors SS Mahmood, MG Fradley, JV Cohen, A Nohria, KL Reynolds, ... Journal of the American College of Cardiology 71 (16), 1755-1764, 2018 | 1210 | 2018 |
| Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations G Curigliano, D Lenihan, M Fradley, S Ganatra, A Barac, A Blaes, ... Annals of Oncology 31 (2), 171-190, 2020 | 793 | 2020 |
| Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement J Herrmann, D Lenihan, S Armenian, A Barac, A Blaes, D Cardinale, ... European heart journal 43 (4), 280-299, 2022 | 284 | 2022 |
| Immune checkpoint inhibitor‐associated myocarditis S Ganatra, TG Neilan The oncologist 23 (8), 879-886, 2018 | 261 | 2018 |
| Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis L Zhang, M Awadalla, SS Mahmood, A Nohria, MZO Hassan, F Thuny, ... European heart journal 41 (18), 1733-1743, 2020 | 255 | 2020 |
| Global longitudinal strain and cardiac events in patients with immune checkpoint inhibitor-related myocarditis M Awadalla, SS Mahmood, JD Groarke, MZO Hassan, A Nohria, A Rokicki, ... Journal of the American College of Cardiology 75 (5), 467-478, 2020 | 209 | 2020 |
| Ibrutinib-associated atrial fibrillation S Ganatra, A Sharma, S Shah, GM Chaudhry, DT Martin, TG Neilan, ... JACC: Clinical Electrophysiology 4 (12), 1491-1500, 2018 | 180 | 2018 |
| Major adverse cardiovascular events and the timing and dose of corticosteroids in immune checkpoint Inhibitor–Associated myocarditis L Zhang, DA Zlotoff, M Awadalla, SS Mahmood, A Nohria, MZO Hassan, ... Circulation 141 (24), 2031-2034, 2020 | 162 | 2020 |
| Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors N Bansal, MJ Adams, S Ganatra, SD Colan, S Aggarwal, R Steiner, ... Cardio-Oncology 5, 1-22, 2019 | 152 | 2019 |
| The novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer S Ganatra, SP Hammond, A Nohria Cardio Oncology 2 (2), 350-355, 2020 | 143 | 2020 |
| Myocardial T1 and T2 mapping by magnetic resonance in patients with immune checkpoint inhibitor–associated myocarditis P Thavendiranathan, L Zhang, A Zafar, ZD Drobni, SS Mahmood, ... Journal of the American College of Cardiology 77 (12), 1503-1516, 2021 | 117 | 2021 |
| Oral nirmatrelvir and ritonavir in nonhospitalized vaccinated patients with coronavirus disease 2019 S Ganatra, SS Dani, J Ahmad, A Kumar, J Shah, GM Abraham, ... Clinical Infectious Diseases 76 (4), 563-572, 2023 | 116 | 2023 |
| Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives S Ganatra, JR Carver, SS Hayek, B Ky, MJ Leja, DJ Lenihan, ... Journal of the American College of Cardiology 74 (25), 3153-3163, 2019 | 83 | 2019 |
| Chimeric antigen receptor T-cell therapy–associated cardiomyopathy in patients with refractory or relapsed non-Hodgkin lymphoma S Ganatra, R Redd, SS Hayek, R Parikh, T Azam, GA Yanik, L Spendley, ... Circulation 142 (17), 1687-1690, 2020 | 76 | 2020 |
| Management of cardiovascular disease during coronavirus disease (COVID-19) pandemic S Ganatra, SS Dani, S Shah, A Asnani, TG Neilan, D Lenihan, B Ky, ... Trends in cardiovascular medicine 30 (6), 315-325, 2020 | 73 | 2020 |
| Management of Patients With Giant Cell Myocarditis: JACC Review Topic of the Week V Bang, S Ganatra, SP Shah, SS Dani, TG Neilan, P Thavendiranathan, ... Journal of the American College of Cardiology 77 (8), 1122-1134, 2021 | 72 | 2021 |
| Cardiotoxicity of immune checkpoint inhibitors RP Patel, R Parikh, KS Gunturu, RZ Tariq, SS Dani, S Ganatra, A Nohria Current Oncology Reports 23, 1-9, 2021 | 69 | 2021 |
| Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors M Awadalla, DLA Golden, SS Mahmood, RM Alvi, ND Mercaldo, ... Journal for immunotherapy of cancer 7, 1-10, 2019 | 68 | 2019 |
| Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series S Ganatra, A Nohria, S Shah, JD Groarke, A Sharma, D Venesy, R Patten, ... Cardio-oncology 5, 1-12, 2019 | 67 | 2019 |
